Bloodless is a widely known term and commonly used to describe surgeries and other procedures performed without the use of homologous/allogeneic blood (someone else’s blood).
For this purpose was designed the www.bloodless.br Web site for showing to both health professionals and the general population, the main therapeutic options and/or strategies for reducing or even avoiding an allogeneic blood transfusion. By using one or multiple therapeutic options is possible to decrease the number of transfused patients, as well as the quantity of blood and blood components administered to each patient.
The benefits are not limited to the economic sphere, but they are also beneficial in relation to incidence and severity of the complications, particularly the mortality, related to the allogeneic blood transfusions.
The BEST BLOOD a patient can receive in a transfusion is your OWN BLOOD. The BLOOD with your OWN DNA.
Since 1960, many doctors have begun the development of protocols to perform surgeries without the need of blood transfusions. One of the leading doctors in this field of the medicine was Dr. Denton Arthur Cooley. In 1962, he performed the first major open heart surgery without the use of blood transfusion. In 1977, he published in one of the major medical journals of international circulation (JAMA), the result of his study after successfully performing 542 cardiac surgeries without the use of blood components. The final conclusion of his research was that “cardiac surgeries can be safely performed without blood transfusion”.
After nearly half a century, the term “BLOODLESS” is increasingly gaining greater importance and popularity for three basic reasons:
I – Blood transfusion results in greater risk than benefit;
II – Blood for transfusion is scarce;
III – Blood transfusion leads to the increasing of hospital costs.
Major hospitals around the world have sought to set protocols in order to ration the use of blood and this has become a hospital quality criteria as required by one of the leading certifying agencies, the Joint Commission International.
Aiming to disseminate clinical and surgical strategies for the management and conservation of the patient own blood (Patient Blood Management – PBM) and, thereby, to reduce or avoid blood transfusions, have emerged at least two medical societies:
1 – SABM (Society for the Advancement of Blood Management)
2 – NATA (Network for Advancement of Transfusion Alternatives)
Given the worldwide concern on transfusional safety, several international authorities, including governments such as Australia, have created a number of features to guide doctors and patients regarding the risks and benefits of a allogeneic blood transfusion.
Below are just some links that have commitment with the Patient Blood Management:
1 – AABB (American Association of Blood Banks) – Associação Americana dos Bancos de Sangue)
2 – Autoridade Nacional do Governo da Austrália (Programa PBM)
3 – In video testimonials from Several International Authorities on Transfusion Safety
4 –BLOOD MYTHS
■ Myth 1: Blood, it’s safer than it’s ever been – PDF
■ Myth 2: A blood transfusion will get my patient home sooner – PDF
■ Myth 3: Blood transfusions improve healing – PDF
■ Myth 4: Autologous blood (pre-donated) is risk-free – PDF
■ Myth 5: Blood, it’s free anyway – PDF
The great challenge of the medicine today is to get a substitute for the allogeneic blood. Researches are well advanced in this setting. It is noted a worldwide effort to change transfusional practice, if possible in the near future.
Unlike the last century, when a standard practice for treating anemia was a blood transfusion, today we already have the power of choosing.
This is real. Options exist. They are effective. They are safe. They save lives. It is everybody’s duty to know them.
BLOODLESS, BLOODLESS, PLEASE! THANK YOU.